Harry R. Trout III

CIK: 0002085123

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (50.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (25.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (25.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ENTA

ENANTA PHARMACEUTICALS INC

Officer

Discretionary Trading P&L

Holdings

Transaction History (4 total)

ENTA
ENANTA PHARMACEUTICALS INC
Dec 5, 2025
Sale(S)
Direct
542 shares at avg. $14.23$8K
ENTA
ENANTA PHARMACEUTICALS INC
Dec 2, 2025
Sale(S)
Direct
380 shares at avg. $13.96$5K
ENTA
ENANTA PHARMACEUTICALS INC
Dec 1, 2025
Tax Payment(F)
Direct
105 shares at avg. $14.12$1K
ENTA
ENANTA PHARMACEUTICALS INC
Nov 25, 2025
Award(A)
Direct
6.5K shares-

		Type	Shares	Price		Ownership
Dec 5, 2025	ENTA ENANTA PHARMACEUTICALS INC	Sale(S)	542	$14.23	$7,713	Direct
Dec 2, 2025	ENTA ENANTA PHARMACEUTICALS INC	Sale(S)	380	$13.96	$5,305	Direct
Dec 1, 2025	ENTA ENANTA PHARMACEUTICALS INC	Tax Payment(F)	105	$14.12	$1,483	Direct
Nov 25, 2025	ENTA ENANTA PHARMACEUTICALS INC	Award(A)	6,463	-	-	Direct

1-4 of 4 transactions

About Trout Harry R. III

Trout Harry R. III (SEC CIK 0002085123) files insider reports with the SEC as Officer of ENANTA PHARMACEUTICALS INC (ENTA).

Signal8 holds 4 ownership filings by Trout Harry R. III (1 Form 3, 3 Form 4), filed between Sep 8, 2025 and Dec 5, 2025. Those filings report 4 transactions, from Nov 25, 2025 to Dec 5, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Trout Harry R. III's filings is in WATERTOWN, MA.

Recent filings by Trout Harry R. III

Dec 5, 2025: Open-market sale of ENTA shares (Form 4, code S).
Dec 2, 2025: Open-market sale of ENTA shares (Form 4, code S).
Dec 1, 2025: Tax withholding of ENTA shares (Form 4, code F).
Nov 25, 2025: Grant or award of ENTA shares (Form 4, code A).

Other insiders filing for ENANTA PHARMACEUTICALS INC (ENTA)

Rottinghaus Scott T., Chief Medical Officer
Vance Terry, Director
Russell Lesley, Director
Peterson Kristine, Director
Hata Yujiro S, Director
FOLETTA MARK G, Director

How to read Form 4 transaction codes